Recombinant CD44-HABD is a novel and potent direct angiogenesis inhibitor enforcing endothelial cell-specific growth inhibition independently of hyaluronic acid binding (Q40516590)
Jump to navigation
Jump to search
scientific article published on October 2004
Language | Label | Description | Also known as |
---|---|---|---|
English | Recombinant CD44-HABD is a novel and potent direct angiogenesis inhibitor enforcing endothelial cell-specific growth inhibition independently of hyaluronic acid binding |
scientific article published on October 2004 |
Statements
1 reference
Recombinant CD44-HABD is a novel and potent direct angiogenesis inhibitor enforcing endothelial cell-specific growth inhibition independently of hyaluronic acid binding (English)
1 reference
Taavi Päll
1 reference
Annica Gad
1 reference
Lagle Kasak
1 reference
Monika Drews
1 reference
Staffan Strömblad
1 reference
Priit Kogerman
1 reference
1 October 2004
1 reference
1 reference
23
1 reference
47
1 reference
7874-7881
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference